Patients in moderate or high/very high risk group were mainly older, male, obese, had a longer duration of diabetes, higher baseline BMI, SBP, DBP, HbA1c, LDL-C and TG level, higher proportion of patients treated with insulin and ACEI/ARB. This evidence concerns the gene INS and diabetes mellitus.